PROM1 and neoplasm: However, in colorectal cancer, CD133 expression is not restricted to CSCs and is found in both normal and tumor cells, with both CD133+ and CD133− cells capable of initiating tumors.133 These findings raise concerns about its reliability as a universal CSC marker.